Silymarin: A novel antioxidant with antiglycation and antiinflammatory properties in vitro and in vivo

Antioxidants and Redox Signaling

Volumn 14, Issue 3, 2011, Pages 353-366

  Wu, Chi Hao ^a   Huang, Shang Ming ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; GLYCOSYLATED ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN P47; SILYMARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CROSS LINKING; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; AORTA; BIOLOGICAL MARKERS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; MALE; MONOCYTES; NADPH OXIDASE; NERVE GROWTH FACTORS; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; S100 PROTEINS; SILYMARIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 78650905604     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3134     Document Type: Article

References (48)

1. Bonnefont-Rousselot D. Antioxidant and anti-AGE therapeutics: evaluation and perspectives. J Soc Bio 195: 391-398, 2001.
2. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5: 561-568, 2002.
3. Cohen MP. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch Biochem Biophys 419: 25-30, 2003.
4. Dasu MR, Devaraj S, and Jialal I. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab 293: E337-E346, 2007.
5. Day JF, Thorpe SR, and Baynes JW. Nonenzymatically glu-cosylated albumin. In vitro preparation and isolation from normal human serum. J Biol Chem 254: 595-597, 1979.
6. Devaraj S, Venugopal SK, Singh U, and Jialal I. Hypergly-cemia induces monocytic release of interleukin-6 via induction of protein kinase C-a and -b. Diabetes 54: 85-91, 2005.
7. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7: 711-724, 2007.
8. Figarola JL, Loera S, Weng Y, Shanmugam N, Natarajan R, and Rahbar S. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia 51: 882-891, 2008.
9. Figarola JL, Shanmugam N, Natarajan R, and Rahbar S. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes 56: 647-655, 2007.
10. Finotti P, Pagetta A, and Ashton T. The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin. Eur J Biochem 268: 2193-2200, 2001.
11. Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, and Osicka TM. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51: 3274-3282, 2002.
12. Guha M, Bai W, Nadler JL, and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275: 17728-17739, 2000.
13. Hayashi T, Ohta Y, and Namiki M. Electron spin resonance spectral study on the structure of the novel free radical products formed by the reactions of sugars with amino acids or amines. J Agric Food Chem 25: 1282-1287, 1977.
14. Hipkiss AR, Brownson C, and Carrier MJ. Carnosine the anti-ageing anti-oxidant dipeptide may react with protein carbonyl groups. Mech Ageing Dev 122: 1431-1445, 2001.
15. Hortelano S, Dewez B, Genaro AM, Díaz-Guerra MJ, and Boscá L. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 21: 776-786, 1995.
16. Hussain SA. Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes. J Med Food 10: 543-547, 2007.
17. Khalifah RG, Chen Y, and Wassenberg JJ. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design. Ann NY Acad Sci 1043: 793-806, 2005.
18. Kiho T, Usui S, Hirano K, Aizawa K, and Inakuma T. Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci Biotechnol Biochem 68: 200-205, 2004.
19. Lee C, Yim MB, Chock, PB, Yim HS, and Kang SO. Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation. J Biol Chem 273: 25272-25278, 1998.
20. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, and Natarajan R. Role of the histone H3 lysine 4 methyltransferase SET7=9 in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283: 26771-26781, 2008.
21. Manuel Y, Keenoy B, Vertommen J, and De Leeuw I. The effect of flavonoid treatment on the glycation and antioxi-dant status in Type 1 diabetic patients. Diabetes Nutr Metab 12: 256-263, 1999.
22. Martinez-Florez S, Gonzalez-Gallego J, Culebras JM, and Tunon MJ. Flavonoids: properties and anti-oxidizing action. Nutr Hosp 17: 271-278, 2002.
23. Miao F, Gonzalo IG, Lanting L, and Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091-18097, 2004.
24. Miao F, Li S, Chavez V, Lanting L, and Natarajan R. Coac-tivator- associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol 20: 1562-1573, 2006.
25. Mizutani K, Ikeda K, Nishikata T, and Yamori Y. Phytoes-trogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens 18: 1833-1840, 2000.
26. Montonen J, Knekt P, Jarvinen R, and Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27: 362-366, 2004.
27. Münch G, Keis R, Wessels A, Riederer P, Bahner U, Heid-land A, Niwa T, Lemke HD, and Schinzel R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35: 669-677, 1997.
28. Nagaraj RH, Shipanova IN, and Faust FM. Protein cross-linking by the Maillard reaction: Isolation characterization and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J Biol Chem 271: 19338-19345, 1996.
29. Nagasawa T, Tabata N, Ito Y, Aiba Y, Nishizawa N, and Kitts DD. Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats. Mol Cell Biochem 252: 141-147, 2003.
30. Nakagawa T, Yokozawa T, Terasawa K, Shu S, and Juneja LR. Protective activity of green tea against free radical- and glucose-mediated protein damage. J Agric Food Chem 50: 2418-2422, 2002.
31. Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, and Portero-Otín M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 11: 3071-3109, 2009.
32. Rahbar S, Yerneni KK, Scott S, Gonzales N, and Lalezari I. Novel inhibitors of advanced glycation endproducts (part II). Mol Cell Biol Res Commun 3: 360-366, 2000.
33. Richard LR and Lloyd RV. Free radical formation from secondary amines in the Maillard reaction. J Agric Food Chem 45: 2413-2418, 1997.
34. Schiekofer S, Andrassy M, Chen J, Rudofsky G, Schneider J, Wendt T, Stefan N, Humpert P, Fritsche A, Stumvoll M, Schleicher E, Häring HU, Nawroth PP, and Bierhaus A. Acute hyperglycemia causes intracellular formation of CML and activation of ras p42=44 MAPK and nuclear factor kappaB in PBMCs. Diabetes 52: 621-633, 2003.
35. Shanmugam N, Kim YS, Lanting L, and Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by li-gation of the receptor for advanced glycation end products. J Bio Chem 278: 34834-34844, 2003.
36. Shanmugam N, Reddy MA, Guha M, and Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256-1264, 2003.
37. Shih PH, Yeh CT, and Yen GC. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J Agric Food Chem 55: 9427-9435, 2007.
38. Thornalley PJ, Langborg A, and Minhas HS. Formation of glyoxal methylglyoxal and 3-deoxyglucosone in the glyca-tion of proteins by glucose Biochem J 344: 109-116, 1999.
39. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419: 31-40, 2003.
40. Venugopal SK, Devaraj S, Yang T, and Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 51: 3049-3054, 2002.
41. Wolff SP and Dean RT. Glucose autoxidation and protein modification. Biochem J 245: 243-250, 1987.
42. Woodside JV, Yarnell JW, McMaster D, Young IS, Harmon DL, McCrum EE, Patterson CC, Gey KF, Whitehead AS, and Evans A. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind randomized factorial-design controlled trial. Am J Clin Nutr 67: 858-866, 1998.
43. Wu CH and Yen GC. Inhibitory effect of naturally occurring flavonoids on advanced glycation endproducts formation. J Agric Food Chem 53: 3167-3173, 2005.
44. Wu CH, Hsieh CL, Song TY, and Yen GC. Inhibitory effects of Cassia tora L. on benzo[a]pyrene-mediated DNA damage toward HepG2 cells. J Agric Food Chem 49: 2579-2586, 2001.
45. Wu CH, Wu CF, Huang HW, Jao YC, and Yen GC. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human mono-cytic THP-1 cells. Mol Nutr Food Res 53: 984-995, 2009.
46. Wu CH, Yeh CT, Shih PH, and Yen GC. Dietary phenolic acids attenuate multiple stages of protein glycation and high-glucose-stimulated proinflammatory IL-1beta activation by interfering with chromatin remodeling and transcription in monocytes. Mol Nutr Food Res 54: 1-14, 2010.
47. Wu JW, Lin LC, and Tsai TH. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. J Ethno-pharmacol 121: 185-193, 2009.
48. Yue DK, McLennan S, Delbridge L, Handelsman DJ, Reeve T, and Turtle JR. The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and non-enzymatic glycosylation. Diabetologia 24: 282-285, 1983.